| Long‐term follow‐up of patients with NAFLD and elevated liver enzymes M Ekstedt, LE Franzén, UL Mathiesen, L Thorelius, M Holmqvist, ... Hepatology 44 (4), 865-873, 2006 | 3068 | 2006 |
| Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up M Ekstedt, H Hagström, P Nasr, M Fredrikson, P Stål, S Kechagias, ... Hepatology 61 (5), 1547-1554, 2015 | 2371 | 2015 |
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 1842 | 2017 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1164 | 2019 |
| Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ... Journal of hepatology 67 (6), 1265-1273, 2017 | 1015 | 2017 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 774 | 2014 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 411 | 2020 |
| Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study M Ekstedt, LE Franzén, UL Mathiesen, M Holmqvist, G Bodemar, ... Journal of hepatology 47 (1), 135-141, 2007 | 403 | 2007 |
| Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long‐term follow‐up study H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ... Hepatology communications 2 (1), 48-57, 2018 | 281 | 2018 |
| Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects S Kechagias, Å Ernersson, O Dahlqvist, P Lundberg, T Lindström, ... Gut 57 (5), 649-654, 2008 | 261 | 2008 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 256 | 2021 |
| Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease M Ekstedt, LE Franzén, M Holmqvist, P Bendtsen, UL Mathiesen, ... Scandinavian journal of gastroenterology 44 (3), 366-374, 2009 | 240 | 2009 |
| Natural history of nonalcoholic fatty liver disease: a prospective follow‐up study with serial biopsies P Nasr, S Ignatova, S Kechagias, M Ekstedt Hepatology communications 2 (2), 199-210, 2018 | 157 | 2018 |
| Natural history of NAFLD/NASH M Ekstedt, P Nasr, S Kechagias Current hepatology reports 16, 391-397, 2017 | 144 | 2017 |
| Effect of high‐fat, high‐protein, and high‐carbohydrate meals on the pharmacokinetics of a small dose of ethanol AW Jones, KÅ Jönsson, S Kechagias British journal of clinical pharmacology 44 (6), 521-526, 1997 | 131 | 1997 |
| Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events J Boursier, H Hagström, M Ekstedt, C Moreau, M Bonacci, S Cure, ... Journal of Hepatology 76 (5), 1013-1020, 2022 | 130 | 2022 |
| Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting LE Franzén, M Ekstedt, S Kechagias, L Bodin Modern pathology 18 (7), 912-916, 2005 | 124 | 2005 |
| Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study S Kechagias, DN Dernroth, A Blomgren, T Hansson, A Isaksson, ... Alcohol and Alcoholism 50 (4), 399-406, 2015 | 122 | 2015 |
| Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease H Hagström, P Nasr, M Ekstedt, P Stål, R Hultcrantz, S Kechagias Clinical gastroenterology and hepatology 17 (6), 1148-1156. e4, 2019 | 102 | 2019 |
| Cardiovascular risk factors in non‐alcoholic fatty liver disease H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, J Askling, R Hultcrantz, ... Liver International 39 (1), 197-204, 2019 | 96 | 2019 |
